{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:33:57Z","timestamp":1769240037861,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jpba.2015.04.044","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T16:30:18Z","timestamp":1431016218000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC\u2013MS\/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin\/naloxone formulation"],"prefix":"10.1016","volume":"114","author":[{"given":"Raquel","family":"Moreno-Vicente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuri\u00f1e","family":"Fern\u00e1ndez-Nieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arantza","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Gasc\u00f3n-Cresp\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mag\u00ed","family":"Farr\u00e9-Albaladejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Igartua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Mar\u00eda","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9566-8403","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Pedraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.04.044_bib0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/jat\/21.4.268","article-title":"Simultaneous determination of heroin, 6-monoacetylmorphine, morphine, and its glucuronides by liquid chromatography-atmospheric pressure ionspray-mass spectrometry","volume":"21","author":"Zuccaro","year":"1997","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2015.04.044_bib0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jchromb.2005.05.048","article-title":"The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry","volume":"824","author":"Rook","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.04.044_bib0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3565(25)30412-X","article-title":"Urinary excretion of heroin and its metabolites in man","volume":"196","author":"Yeh","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2015.04.044_bib0155","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1440-1681.1999.03090.x","article-title":"Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine","volume":"26","author":"Salmon","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jpba.2015.04.044_bib0160","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.2042-7158.1992.tb05474.x","article-title":"The effect of temperature and pH on the deacetylation of diamorphine in aqueous solution and in human plasma","volume":"44","author":"Barrett","year":"1992","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jpba.2015.04.044_bib0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0885-3924(01)00369-4","article-title":"Low-dose naloxone reverses opioid-induced constipation and analgesia","volume":"23","author":"Liu","year":"2002","journal-title":"J. Pain Symp. Manag."},{"key":"10.1016\/j.jpba.2015.04.044_bib0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2013.09.036","article-title":"Determination of naloxone-3-glucuronide in human plasma and urine by HILIC-MS\/MS","volume":"942\u2013943","author":"Dong","year":"2013","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.04.044_bib0175","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.talanta.2006.07.035","article-title":"Simultaneous analysis of naltrexone and its major metabolite, 6-\u03b2-naltrexol, in human plasma using liquid chromatography-tandem mass spectrometry: application to a parent-metabolite kinetic model in humans","volume":"71","author":"Yun","year":"2007","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2015.04.044_bib0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2008.08.021","article-title":"An automated, highly sensitive LC-MS\/MS assay for the quantification of the opiate antagonist naltrexone and its major metabolite 6\u03b2-naltrexol in dog and human plasma","volume":"874","author":"Clavijo","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.04.044_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0378-4347(97)00149-7","article-title":"High-performance liquid chromatographic monitoring of intravenously administered diacetylmorphine and morphine and their metabolites in human plasma","volume":"694","author":"Bourquin","year":"1997","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.04.044_bib0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0378-4347(91)80454-K","article-title":"High-performance liquid chromatographic determination of morphine, morphine-3-glucuronide, morphine-6-glucuronide and codeine in biological samples using multi-wavelength forward optical detection","volume":"571","author":"Chari","year":"1991","journal-title":"J. Chormatogr. B"},{"key":"10.1016\/j.jpba.2015.04.044_bib0195","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00007691-199105000-00007","article-title":"A simple, rapid method for the simultaneous determination of morphine and its principal metabolites in plasma using high-performance liquid chromatography and fluorometric detection","volume":"13","author":"Glare","year":"1991","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.jpba.2015.04.044_bib0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jat\/21.2.127","article-title":"Determination of heroin, 6-acetylmorphine, and morphine in biological fluids using their propionyl derivatives with ion trap GC-MS","volume":"21","author":"Guillot","year":"1997","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2015.04.044_bib0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0731-7085(94)00121-H","article-title":"Analysis of unconjugated morphine, codeine, normorphine and morphine as glucuronides in small volumes of plasma from children","volume":"13","author":"Watson","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.04.044_bib0210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1570-0232(02)00726-2","article-title":"Rapid and simple method to determine morphine and its metabolites in rat plasma by liquid chromatography-mass spectrometry","volume":"787","author":"Projean","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.04.044_bib0215","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.jchromb.2011.06.039","article-title":"Development and validation of a sensitive LC\/MS\/MS method for the simultaneous determination of naloxone and its metabolites in mouse plasma","volume":"879","author":"Jiang","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.04.044_bib0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jpba.2013.02.027","article-title":"Simultaneous analysis of codeine and its active metabolites in human plasma using liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study after oral administration of codeine","volume":"78\u201379","author":"Wu","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.04.044_bib0225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jat\/34.4.177","article-title":"Method for the quantification of diamorphine and its metabolites in pediatric plasma samples by liquid chromatography-tandem mass spectrometry","volume":"34","author":"Al-Asmari","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2015.04.044_bib0230","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpba.2012.10.033","article-title":"Stability of heroin, 6-monoacetylmorphine, and morphine in biological samples and validation of an LC-MS assay for delayed analyses of pharmacokinetic samples in rats","volume":"74","author":"Jones","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.04.044_bib0235","series-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency (EMEA)","year":"2011"},{"key":"10.1016\/j.jpba.2015.04.044_bib0240","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0021-9673(01)95317-8","article-title":"Simple high-performance liquid chromatographic method for the separation of 3, 6- diacetylmorphine hydrochloride (heroin) and hydrolysis products","volume":"171","author":"Poochikian","year":"1979","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jpba.2015.04.044_bib0245","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jat\/33.7.345","article-title":"Determination of heroin and its main metabolites in small sample volumes of whole blood and brain tissue by reversed-phase liquid chromatography- tandem mass spectrometry","volume":"33","author":"Karinen","year":"2009","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2015.04.044_bib0250","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM198405103101902","article-title":"The pharmacokinetics of heroin in patients with chronic pain","volume":"310","author":"Inturrisi","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2015.04.044_bib0255","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157488406775268219","article-title":"Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature","volume":"1","author":"Rook","year":"2006","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2015.04.044_bib0260","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/clpt.1992.106","article-title":"Treatment of opioid-induced constipation with oral naloxone: a pilot study","volume":"52","author":"Culpepper-Morgan","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2015.04.044_bib0265","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0009-9236(03)00199-1","article-title":"Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts","volume":"74","author":"Girardin","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2015.04.044_bib0270","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejps.2008.11.008","article-title":"Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets","volume":"36","author":"Perger","year":"2009","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515002770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515002770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T21:02:04Z","timestamp":1748379724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515002770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":27,"alternative-id":["S0731708515002770"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.04.044","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC\u2013MS\/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin\/naloxone formulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}